MGMT and glioblastoma: Pre-treatment with 26S-proteasome inhibitor bortezomib prior to temozolomide caused MGMT mRNA and protein depletion in glioblastoma cell lines, causing cell death in vitro and prolonging survival in orthotopic mice [182].